Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alpha-Ionone SCHEMBL112671 | 1.00 | ALDH1A1 (0.71) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| Alpha-Ionone SCHEMBL5591022 | 1.00 | ALDH1A1 (0.71) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| Alpha-Ionone SCHEMBL5590917 | 1.00 | ALDH1A1 (0.71) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| Alpha-Ionone SCHEMBL5590918 | 1.00 | ALDH1A1 (0.71) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| Alpha-Ionone SCHEMBL112670 | 1.00 | ALDH1A1 (0.71) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| Alpha-Ionone SCHEMBL901102 | 1.00 | ALDH1A1 (0.71) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| Alpha-Ionone SCHEMBL19816175 | 0.98 | ALDH1A1 (0.69) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL954796 | 0.87 | ALDH1A1 (0.71) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL14566205 | 0.87 | ALDH1A1 (0.71) | ALDH1A1CYP3A4ALOX15TDP1KDM4E | |
| SCHEMBL954794 | 0.87 | ALDH1A1 (0.71) | ALDH1A1CYP3A4ALOX15TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4519404-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | Firmenich SA (CH) | 2025-03-12 | — | — | EP | claimed |
| WO-2023247604-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | claimed |
| EP-4161476-A1 | COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF SWEAT MALODOR | Firmenich SA (CH) | 2023-04-12 | — | — | EP | claimed |
| WO-2022084548-A1 | COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF SWEAT MALODOR | FIRMENICH SA (CH) | 2022-04-28 | — | — | WO | claimed |
| US-20160207765-A1 | HYDROGEN GENERATOR, AND HYDROGEN GENERATION CONTAINER | TAKEHARA TAKASHI (JP) | 2016-07-21 | — | — | US | claimed |
| EP-4661689-A1 | MICROPARTICLES CONTAINING ALGAL PROTEINS AND USES THEREOF | Firmenich SA (CH) | 2025-12-17 | — | — | EP | disclosed |
| EP-4633790-A1 | POLYAMIDE-BASED MICROCAPSULES | Firmenich SA (CH) | 2025-10-22 | — | — | EP | disclosed |
| EP-4633791-A1 | PROTEIN-BASED MICROCAPSULES | Firmenich SA (CH) | 2025-10-22 | — | — | EP | disclosed |
| WO-2024200171-A1 | MICROPARTICLES CONTAINING ALGAL PROTEINS AND USES THEREOF | FIRMENICH SA (CH) | 2024-10-03 | — | — | WO | disclosed |
| CN-118294603-A | Research method for interaction of key chiral compounds in Longjing tea | 上海应用技术大学 | 2024-07-05 | — | — | CN | disclosed |
| WO-2024126450-A1 | PROTEIN-BASED MICROCAPSULES | FIRMENICH SA (CH) | 2024-06-20 | — | — | WO | disclosed |
| EP-4376996-A1 | PLANT PROTEIN-BASED MICROCAPSULES | Firmenich SA (CH) | 2024-06-05 | — | — | EP | disclosed |
| US-8053592-B2 | Method for producing optically active α-ionone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-11-08 | — | — | US | disclosed |
| US-20110118500-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE a-IONONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-05-19 | — | — | US | disclosed |
| US-20110118500-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE a-IONONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-05-19 | — | — | US | disclosed |
| US-7902404-B2 | Method for producing optically active α-ionone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-7902404-B2 | Method for producing optically active α-ionone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20090216039-A1 | Method for Producing Optically Active Alpha-Ionone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-08-27 | — | — | US | disclosed |
| US-20090216039-A1 | Method for Producing Optically Active Alpha-Ionone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-08-27 | — | — | US | disclosed |
| JP-2007077226-A | FLAVOR AND FRAGRANCE COMPOSITION | TAKASAGO INTERNATL CORP | 2007-03-29 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118500-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE a-IONONE | INF2, HSD17B1, AGL | ALDH1A1 322/4885CYP3A4 183/4885ALOX15 257/4885 |
| US-20090216039-A1 | Method for Producing Optically Active Alpha-Ionone | HSD17B1, ENO1, INF2 | ALDH1A1 357/4885CYP3A4 196/4885ALOX15 373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.